In-vitro assays revealed that decreased SNHG15 inhibited PC cell proliferative capacities, promoted G1/G0 phase arrest, and activated apoptosis, whereas in-vivo assay demonstrated that SNHG15 downregulation suppressed PC cell tumorigenesis. This evidence concerns the gene SNHG15 and pachyonychia congenita.